Last reviewed · How we verify

NCT06579118

The Impact of Laughter Yoga on Symptom Management and Quality of Life in Postmenopausal Women

Completed NA Last updated 17 December 2025
What this trial tests

NA trial testing Laughter yoga in Menopause in 120 participants. Completed in 28 August 2024.

Timeline
25 August 2023
Primary endpoint
15 December 2023
28 August 2024

Quick facts

Lead sponsorAtaturk University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment120
Start date25 August 2023
Primary completion15 December 2023
Estimated completion28 August 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Ataturk University

Who can join

45 and older, female only, with Menopause. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to assess the impact of laughter yoga intervention on symptomatology and quality of life among postmenopausal women.The research was conducted in a randomized controlled experimental design.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Laughter yoga

Trials testing the same drug.

Other recruiting trials for Menopause

Currently open trials in the same condition.

Other Ataturk University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06579118.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing